Browsing by Author "Cressey, Tim R."

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Single dose abacavir pharmacokinetics and safety in neonates exposed to human immunodeficiency virus (HIV)
    (Oxford University Press, 2021-06) Bekker, Adrie; Decloedt, Eric H.; Slade, Gretchen; Cotton, Mark F.; Rabie, Helena; Cressey, Tim R.
    Abacavir is a potential option for prophylaxis and early treatment of human immunodeficiency virus (HIV), but no data are available in neonates. Ten neonates administered a single abacavir dose of 8 mg/kg before 15 days of life had substantially higher exposures than those reported in infants and children, with no reported adverse events.